Pharmaceuticals
An Experienced Hand Launches 3 ETFs Under His Own Flag
ETF veteran Kevin Kelly is the force behind Kelly ETFs, which this month introduced three funds with distinctly different focuses.
Johnson & Johnson May Shed Some Tears in This Bear Market Decline
JNJ has been in a longer-term uptrend but that may not be enough to keep the rally going.
Buy Moderna? A Subscriber Wants to Know
Let's take a look at the charts and indicators.
Fast Track or Slow Track, I Still Believe in Genprex's Long-Term Story
This health biotech has been dealt some tough hands, but is still at the table. Here's my take.
BioMarin Pharmaceutical Is Ready to Start a Fresh Advance
Here's where aggressive traders could go long BMRN.
Zoetis Could Be Seeing Its Correction Coming to an End
The shares of the animal health company could be finding a bottom after losing substantial ground since the start of the year.
CVS Is a Good Place to Hide in a Volatile Marketplace: What Traders Can Do
The firm certainly seems to have the wind at its sails right now.
Walgreens Boots Alliance Is Ready to Break Out of Its Lengthy Consolidation
Here's where traders could go long.
Caution Signs Are Flashing in My Mind as the New Year Begins
The biotech sector looks ripe for staging a comeback, but a significant geopolitical event could throw the entire market for a loop.
Options Play of the Week: Take a Chance on This Small Biopharma in 2022
After a huge drop in recent weeks, these shares look oversold -- and an insider seems to agree.